Condition: Total Hip Arthroplasty · Survival, Prosthesis · Sponsor: Medacta International SA
The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty. The primary endpoint is the 10-year life span of the prosthesis according to the Kaplan Meier curve.
This description comes directly from the study's public registry record.
Arianna Girardi · +41 91 696 60 60 · girardi@medacta.ch
Always discuss trial participation with your own doctor first.
| Centre Orthopédique Médico-Chirurgical de Dracy Le Fort | Dracy-le-Fort, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05818891